Preparation of radioactive core-shell type 198Au@SiO2 nanoparticles as a radiotracer for industrial process applications

Opportunities in the Synthesis and Design of Radioactive Thin Films and Nanoparticles

Studies of radioactive isotopes at the liquid-solid or gas-solid interface are enabling a detailed mechanistic understanding of the effects of radioactive decay on physical, biological, and chemical systems. In recent years, there has been a burgeoning interest in using radioactive isotopes for both imaging and therapeutic purposes by attaching them to the surface of colloidal nanoparticles. By merging the field of nanomedicine with the more mature field of internal radiation therapy, researchers are discovering new ways to diagnose and treat cancer. In this Perspective, we discuss state-of-the-art radioactive thin films as applied to both well-defined surfaces and more complex nanoparticles. We highlight the design considerations that are unique to radioactive films, which originate from the damaging and potentially self-destructive emissions produced during radioactive decay, and highlight future opportunities in the largely underexplored area between radioisotope chemistry and nanoscience.

Review of Therapeutic Applications of Radiolabeled Functional Nanomaterials

In the last two decades, various nanomaterials have attracted increasing attention in medical science owing to their unique physical and chemical characteristics. Incorporating radionuclides into conventionally used nanomaterials can confer useful additional properties compared to the original material. Therefore, various radionuclides have been used to synthesize functional nanomaterials for biomedical applications. In particular, several α- or β-emitter-labeled organic and inorganic nanoparticles have been extensively investigated for efficient and targeted cancer treatment. This article reviews recent progress in cancer therapy using radiolabeled nanomaterials including inorganic, polymeric, and carbon-based materials and liposomes. We first provide an overview of radiolabeling methods for preparing anticancer agents that have been investigated recently in preclinical studies. Next, we discuss the therapeutic applications and effectiveness of α- or β-emitter-incorporated nanomaterials in animal models and the emerging possibilities of these nanomaterials in cancer therapy.

Preparation of the Nanostructured Radioisotope Metallic Oxide by Neutron Irradiation for Use as Radiotracers

Metallic oxides manganese dioxide (MnO2), samarium oxide (Sm2O3), and dysprosium oxide (Dy2O3) with nanorod-like structures were synthesized by the hydrothermal synthesis method, respectively. Subsequently, the nanostructured radioisotopes MnO2 with Mn-56, Sm2O3 with Sm-153, and Dy2O3 with Dy-165 were prepared by neutron irradiation from the HANARO research reactor, respectively. The three different elements, Mn, Sm, and Dy, were selected as radiotracers because these elements can be easily gamma-activated from neutrons (activation limits: 1 picogram (Dy), 1–10 picogram (Mn), 10–100 picogram (Sm)). Furthermore, the synthesized radioisotopes can be used as radiotracers in Prompt Gamma Neutron Activation Analysis as the rare earth metals Dy and Sm were not present in the Korean environment. The successful synthesis of the radioisotope metallic oxides was confirmed by Transmission Electron Microscopy (TEM), Energy Dispersive X-ray Spectrometry (EDS), X-ray Diffraction (XRD) analysis, and gamma spectroscopy analysis. The synthesized nanostructured radioisotope metallic oxides may be used as radiotracers in scientific, environmental, engineering, and industrial fields.

Synthesis, characterization and application of Au-198 nanoparticles as radiotracer for industrial applications

This paper describes synthesis and characterization of radioactive gold nanoparticles ((198)Au-NPs), and explores their utility as a radiotracer for tracing an aqueous phase in a continuous laboratory-scale bubble column at ambient conditions. The performance of the (198)Au-NPs as a radiotracer was compared with the results obtained with a conventional radiotracer i.e. bromine-82 ((82)Br) as ammonium bromide and found to be identical. A tank-in-series with backmixing model (TISBM) was used to simulate the RTDs of the aqueous phase and characterize flow in the bubble column.

Visualisation of dual radiolabelled poly(lactide-co-glycolide) nanoparticle degradation in vivo using energy-discriminant SPECT

The determination of nanoparticle (NP) stability and degradation in vivo is essential for the accurate evaluation of NP biodistribution in medical applications and for understanding their toxicological effects. Such determination is particularly challenging because NPs are extremely difficult to detect and quantify once distributed in a biological system. Radiolabelling with positron or gamma emitters and subsequent imaging studies using positron emission tomography (PET) or single-photon emission computerised tomography (SPECT) are some of the few valid alternatives. However, NPs that degrade or radionuclides that detach or are released from the NPs can cause artefact. Here, submicron-sized poly(lactide-co-glycolide) nanoparticles (PLGA-NPs) stabilised with bovine serum albumin (BSA) were dual radiolabelled using gamma emitters with different energy spectra incorporated into the core and coating. To label the core, ¹¹¹In-doped iron oxide NPs were encapsulated inside PLGA-NPs during NP preparation, and the BSA coating was labelled by electrophilic substitution using ¹²⁵I. After intravenous administration into rats, energy-discriminant SPECT resolved each radioisotope independently. Imaging revealed different fates for the core and coating, with a fraction of the two radionuclides co-localising in the liver and lungs for long periods of time after administration, suggesting that NPs are stable in these organs. Organ harvesting followed by gamma counting corroborated the SPECT results. The general methodology reported here represents an excellent alternative for visualising the degradation process of multi-labelled NPs in vivo and can be extended to a wide range of engineered NPs.

Synthesis and characterization of coordination polymer nanoparticles as radioisotope tracers

Coordination polymer nanoparticles (NPs) with gamma-emitting nuclide (Au-198), 411keV, 675keV, 822keV and 1087keV were prepared by coordination polymerization of the radioisotope Au(3+) ions and 1,4-bis(imidazole-1-ylmethyl)benzene in an aqueous solution at room temperature for 3h. Here, the radioisotope Au(3+) ions were prepared by dissolution of Au-198 foil, which was prepared by neutron irradiation from the HANARO reactor, in KCN aqueous solution. The successful synthesis of the radioisotope coordination polymer NPs with 5±0.5nm was confirmed via UV-vis spectroscopy, Transmission Electron Microscopy (TEM), Energy Dispersive X-ray Spectrometry (EDXS), Thermogravimetric analysis (TGA), and Gamma spectroscopy analysis. The synthesized radioisotope coordination polymer NPs can be used as radiotracers in science, engineering, and industrial fields.

Biodistribution of different sized nanoparticles assessed by positron emission tomography: a general strategy for direct activation of metal oxide particles

The extraordinary small size of NPs makes them difficult to detect and quantify once distributed in a material or biological system. We present a simple and straightforward method for the direct proton beam activation of synthetic or commercially available aluminum oxide NPs (Al2O3 NPs) via the 16O(p,α)13N nuclear reaction in order to assess their biological fate using positron emission tomography (PET). The radiolabeling of the NPs does not alter their surface or structural properties as demonstrated by TEM, DLS, and ζ-potential measurements. The incorporation of radioactive 13N atoms in the Al2O3 NPs allowed the study of the biodistribution of the metal oxide NPs in rats after intravenous administration via PET. Despite the short half-life of 13N (9.97 min), the accumulation of NPs in different organs could be measured during the first 68 min after administration. The percentage amount of radioactivity per organ was calculated to evaluate the relative amount of NPs per organ. This simple and robust activation strategy can be applied to any synthetic or commercially available metal oxide particle.

Surface Enhanced Raman Scattering (SERS) Studies of Gold and Silver Nanoparticles Prepared by Laser Ablation

Gold and silver nanoparticles (NPs) were prepared in water, acetonitrile and isopropanol by laser ablation methodologies. The average characteristic (longer) size of the NPs obtained ranged from 3 to 70 nm. 4-Aminobenzebethiol (4-ABT) was chosen as the surface enhanced Raman scattering (SERS) probe molecule to determine the optimum irradiation time and the pH of aqueous synthesis of the laser ablation-based synthesis of metallic NPs. The synthesized NPs were used to evaluate their capacity as substrates for developing more analytical applications based on SERS measurements. A highly energetic material, TNT, was used as the target compound in the SERS experiments. The Raman spectra were measured with a Raman microspectrometer. The results demonstrate that gold and silver NP substrates fabricated by the methods developed show promising results for SERS-based studies and could lead to the development of micro sensors.

Synthesis and characterization of radioisotope nanospheres containing two gamma emitters

Silica-coated gold-silver alloy nanospheres prepared by Stöber's method were irradiated in a nuclear reactor to prepare radioisotope nanospheres for use as radiotracers. The radioisotope nanospheres included two gamma nuclides: (i) Au-198, emitting major photons with 0.412 MeV and (ii) Ag-108, emitting photons with 0.434 and 0.633 MeV. The nanospheres shell and core diameters were 100-112 nm and 20-50 nm, respectively, depending on their preparation. The gamma-emitting nanospheres could be used as tracers in high-temperature petrochemical and refinery processes in which conventional organic radioactive labels will decompose.